Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute Infection

Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute Infection

Jillian Kallman Price,1 Lynn H Gerber,1,2 Maria Stepanova,1– 3 Leyla de Avila,1 Ali A Weinstein,4 Huong Pham,1 Fatema Nader,1 Mariam Afendy,1 Kathy Terra,3 Patrick Austin,1 Wisna’odom Keo,1 Andrei Racila,1 James Michael Estep,1 Suzannah Gerber,1 Manisha Verma,1 Pegah Golabi,1 Brian P Lam,1– 3 Zobair...

Full description

Bibliographic Details
Main Authors: Price JK, Gerber LH, Stepanova M, de Avila L, Weinstein AA, Pham H, Nader F, Afendy M, Terra K, Austin P, Keo W, Racila A, Estep JM, Gerber S, Verma M, Golabi P, Lam BP, Younossi Z
Format: Article
Language:English
Published: Dove Medical Press 2023-04-01
Series:International Journal of General Medicine
Subjects:
monoclonal antibodies
patient-reported outcomes
symptom burden
recovery
covid-19
Online Access:https://www.dovepress.com/post-acute-sars-cov-2-symptoms-are-fewer-less-intense-over-time-in-peo-peer-reviewed-fulltext-article-IJGM

Internet

https://www.dovepress.com/post-acute-sars-cov-2-symptoms-are-fewer-less-intense-over-time-in-peo-peer-reviewed-fulltext-article-IJGM

Similar Items